LinkedIn




Hot Topics


CEI Line: 1-866-637-2342

Updated March 2015

CEI PEP Line is now the CEI Line: 1-866-637-2342

CEI provides this toll-free number for clinicians in New York State to discuss PEP, PrEP, HIV, HCV and STD management with a specialist.

For more information about CEI and the other disease specific services of the CEI Line, please visit http://www.ceitraining.org/.

CEI Line: 1-866-637-2342

 

^ Return to Top


Dear Medical Provider Letter: Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection

Posted April 2015

Dear Medical Provider:

Post-exposure prophylaxis (PEP) to prevent HIV infection is a proven, yet underutilized method of preventing new cases of HIV infection. This letter is written to disseminate the updated 2014 New York State Department of Health (NYSDOH) clinical guidelines and to encourage clinical providers across NYS to be vigilant in identifying cases where PEP may be prescribed to prevent HIV infection.

Exposure to HIV is a medical emergency. Given a brief window of opportunity, health care providers must act quickly to recommend and initiate PEP in cases where a patient has had a recent significant exposure that could lead to HIV infection. It is important to note that the current regimen used in PEP is more effective and better tolerated than previous regimens. Clinical providers should triage patients who may require PEP as urgent cases because PEP should ideally be initiated within two hours and no later than 36 hours after exposure. A best practice is to administer the first dose of PEP while conducting a baseline evaluation to establish that the patient: 1) is not already HIV-infected; and 2) has a high risk of exposure to HIV.

Below are links to the updated clinical guidelines for prescribing PEP and other resources available from the NYSDOH to support the provision of PEP:

To download the letter, please click here.

 

^ Return to Top


Medicaid Update: March

Posted March 2015

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the March 2015 Medicaid Update.

Please click the link below to download the current edition.
http://www.health.ny.gov/health_care/medicaid/program/update/2015/mar15_mu.pdf (PDF)

To see a list of all of the 2015 DOH Medicaid Updates, please visit http://www.health.ny.gov/health_care/medicaid/program/update/2015/index.htm

 

^ Return to Top


Healthcare Stories Project: Activity 2 Materials

Posted January 2015



Materials are now available for Activity 2 of the Healthcare Stories Project, “How is Today’s Visit Going?,” including a poster, instructional guide, and activity worksheets. This installment is the second in a three-part initiative to add a critically important dimension to quality of care programs across New York State through the engagement of patients in their care experience, and the enhancement of consumer involvement at the programmatic level.

Activity two helps healthcare organizations understand what each part of a medical visit is like for healthcare users. This activity will enable healthcare staff to learn how to analyze information healthcare users share about their experiences, and apply this learning to develop quality improvement projects.

For more information, please click here.

 

^ Return to Top


New York State Testing Law: Journal of Acquired Immune Deficiency Syndromes (JAIDS) Supplement

Posted February 2015

JAIDS NYS Testing Law Cover

The New York State HIV Testing Law JAIDS Supplement

The New York State Department of Health AIDS Institute is pleased to announce the release of the January 1, 2015, Journal of Acquired Immune Deficiency Syndromes (JAIDS) Supplement, entitled New York State HIV Testing Law (Implementation Research). Guest-edited by Guthrie S. Birkhead, MD, MPH, Deputy Commissioner, Office of Public Health, New York State Department of Health, the Supplement contains 10 articles written by AIDS Institute staff and partners at the New York State Department of Health, New York City Department of Health and Mental Hygiene, the University at Albany, and Baruch College, City University of New York. These articles examine the evolution of New York State’s 2010 HIV Testing Law, its challenges, impact, and future directions. JAIDS is one of the world’s foremost peer-reviewed journals in HIV/AIDS science, epidemiology, and prevention.

About the New York State HIV Testing Law
In 2010, NYS authorized major changes to its HIV Testing Law. Among the changes, healthcare providers became required to offer HIV testing to all persons aged 13-64 and to make a referral for medical care for anyone with confirmed HIV infection. Consumers no longer had to provide written consent for HIV rapid tests (oral consent was sufficient). These changes brought NYS into closer alignment with the CDC’s recommendation that HIV testing be routinely offered in medical care settings on an opt-out basis. The changes also enhanced the ability of providers to adopt practices that support the National HIV/AIDS Strategy, released just two months prior to the 2010 testing law. The mandate to provide linkage to medical care for all newly diagnosed HIV-infected persons later became a cornerstone in Governor Cuomo’s Ending the Epidemic plan.

About the JAIDS Supplement
This JAIDS Supplement is a compendium of articles that assess HIV testing and linkage to care before and after the 2010 HIV Testing Law. These activities were the first of their kind to measure testing and linkage trends following statewide implementation of routine testing and serve as a model for other jurisdictions considering similar legislation or assessing the impacts of their own testing law. Several findings described in the Supplement suggest that the HIV Testing Law had the intended effect of increasing HIV testing among persons aged 13-64 and that persons who were offered the test were likely to accept it. Collectively, the studies highlight the potential impact of public health law on key public health goals but, as the final article in the Supplement suggests, policy-level change alone will not end the epidemic. Alongside a growing continuum of interventions, however, the 2010 testing law creates the foundational framework for achieving key provisions of the Ending the Epidemic plan, such as increasing HIV testing, reducing the number of people unaware they are infected with HIV, and improving rates of timely entry into medical care for persons newly diagnosed with HIV.

Featured Articles
Birkhead GS, O’Connell DA, Leung SJ, et al. Evaluating the New York State 2010 HIV testing law amendments: Context, challenges, and conclusions. JAIDS 2015;68(Suppl 1):S1-S4.

O’Connell DA, Martin EG, Cutler B, et al. The evolution of HIV testing requirements in New York State, 1989–2013. JAIDS 2015;68(Suppl 1):S5-S9.

Lazariu V, Parker MM, Leung SJ, et al. New York State 2010 HIV testing law: An evaluation of testing rates using laboratory D. JAIDS 2015;68(Suppl 1):S10-S14.

Newton-Dame R, Wang JJ, Kim MS, et al. Evaluating the 2010 New York State HIV testing law in NYC ambulatory practices using electronic health records. JAIDS 2015;68(Suppl 1):S15-S20.

Zielinski M, Leung SJ, Akkaya-Hocagil T, et al. Correlates of routine HIV testing practices: A survey of New York State primary care physicians, 2011. JAIDS 2015;68(Suppl 1):S21-S29.

Ortega-Peluso C, Akkaya-Hocagil T, Leung SJ, et al. Routine HIV testing capacity, practices, and perceptions among school-based health center providers in New York State after enactment of the 2010 amended HIV testing law. JAIDS 2015;68(Suppl 1):S30-S36.

Leung SJ, Sinclair AH, Battles HB, et al. HIV test offers and acceptance: New York State findings from the behavioral risk factor surveillance system and the National HIV Behavioral Surveillance, 2011–2012. JAIDS 2015;68(Suppl 1):S37-S44.

Edelstein ZR, Myers JE, Cutler BH, et al. HIV testing experience in New York City: offer of and willingness to test in the context of new legal support of routine testing. JAIDS 2015;68(Suppl 1):S45-S53.

Gordon DE, Bian F, Anderson BJ, et al. Timing of entry to care by newly diagnosed HIV cases before and after the 2010 New York State HIV testing law. JAIDS 2015;68(Suppl 1):S54-S58.

Martin EG, MacDonald RH, Smith LC, et al. Mandating the offer of HIV testing in New York: Simulating the epidemic impact and resource needs. JAIDS 2015;68(Suppl 1):S59-S67.

 

^ Return to Top


ACTHIV Free Online CME/CNE

Posted February 2015

ACCESS THE BEST OF THE 2014 AMERICAN CONFERENCE FOR THE TREATMENT OF HIV (ACTHIV)

FREE CME/CNE

Activities in this curriculum have been approved for AMA PRA Category 1 Credits™ and nursing CE Credits.

The American Conference for the Treatment of HIV (ACTHIV) is the premier conference in the US dedicated exclusively to frontline clinicians caring for individuals living with HIV infection. The conference delivers information to learners on new developments and research findings that can be rapidly translated and directly applied to the clinical setting. Well respected within the healthcare community, this year’s conference provided a large variety and number of high caliber speakers and sessions.

If you couldn’t attend the ACTHIV 2014 Conference, or were there but missed a key session, now you have a convenient way to catch up on what you may have missed. A number of sessions from the 2014 meeting have been recorded and are now available for free viewing.

Access the ACTHIV 2014 – CME/CNE-Certified Web Curriculum to:

  • View top rated courses presented at the 2014 annual conference
  • Learn best practices from experts in your field
  • View these modules in the comfort of your office or home
  • Receive continuing education credits (CME/CNE credit is awarded for each module)

After viewing the course, follow the link in the course instructions to receive CME/CNE credit.* Courses are free and available online for credit at any time through October 2015:

Initial Evaluation of an HIV Patient: Initiating Antiretroviral Therapy (When, What and How)
Rajesh T. Gandhi, MD
Associate Professor of Medicine
Harvard Medical School;
Director of HIV Clinical Services and Education
Massachusetts General Hospital

The Epidemiology of HIV and its Relevance to the Clinician
Patrick Sullivan, DVM, PhD
Professor of Epidemiology
Emory University’s Rollins School of Public Health;
Co-Director, Prevention Sciences Core
Emory’s Center for AIDS Research

Chronic Complications of HIV Disease
Pablo Tebas, MD
Associate Professor of Medicine
University of Pennsylvania School of Medicine
Principal Investigator in the AIDS Clinical Trials Unit
University of Pennsylvania

Current State of Treatment for HCV
Nancy Reau, MD
Associate Professor of Medicine
University of Chicago School of Medicine

Visit CEI for these and other on line courses.

 

^ Return to Top


Updated HHS Pediatric Antiretroviral Treatment Guidelines Released

Posted March 2015

Updated HHS Pediatric Antiretroviral Treatment Guidelines Released

The HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children announces the release of the updated Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.

For a complete preview of key updates to the guidelines, please see What’s New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the text and tables of the guidelines.

To view or download the guidelines, go to the Pediatric Guidelines section of AIDSinfo. Separate PDF files of the tables or recommendations can also be downloaded from the page.

 

^ Return to Top


Quick News Update from OMD AIDS Institute: February 17

Posted February 2015

OMD SCREENSHOT – February 17, 2015

Here is important information from the Office of the Medical Director (OMD) AIDS Institute:

Nominations are Now Being Accepted for Clinical Members of the New York State Department of Health AIDS Institute’s Medical Care Criteria Committee (MCCC).

The MCCC develops clinical guidelines for the care of adults with HIV infection. The Committee is accepting nominations for new clinical members with an expertise in HIV medicine who practice in New York State and have extensive experience in managing patients with HIV infection. Committee members should have familiarity with the evidence base of HIV medicine, as they must critically evaluate emerging research and scientific information to craft new guidelines and revise existing ones. The MCCC seeks representation from all practice settings and locations and has a particular need to fill the vacancies of upstate members. The Committee is seeking new members who would be available to serve a 4-year term beginning in April 2015.

Nominations must be received by Monday, March 16, 2015.

For more information and instructions regarding nominations, click here.

 

^ Return to Top


HEALTHQUAL International: February 10

Posted February 2015

HEALTHQUAL International


This issue of the HEALTHQUAL Updatehighlights a community-based approach to improving infant and young child feeding practices in Zambia with a focus on imparting knowledge and skills to caregivers in globally recommended feeding practices.

This project demonstrates the importance of community involvement in improvement efforts and emphasizes their critical role in outreach activities and in identifying malnourished children. This approach proved to accelerate outreach efforts that are key to conducting targeted nutrition related activities and reducing mortality in children under-5 years.

Click here to read more

HEALTHQUAL Performance Measurement Data Report

HEALTHQUAL Performance Measurement Data Report – 2015
This report reflects national commitment to building performance measurement systems for improvement among Ministries of Health in Uganda, Mozambique, Namibia, Haiti, Guyana, Kenya, Vietnam and Zimbabwe. Progress has been achieved with ongoing coordination and planning with US Government teams and other implementing partners in these countries. In each case, HEALTHQUAL has facilitated the adaptation of a model responding to differences in health care systems, national guidelines and local resources, which has been designed to measure core aspects of care.

Access the full report here

For more information, please visit http://www.healthqual.org/

 

^ Return to Top


Opioid Overdose Prevention Pilot Program Trains Inmates to Use Naloxone

Posted February 2015

DOCCS, DOH, and HRC Announce New Opioid Program to Address Growing Opioid Crisis
Pilot Program trains inmates to use naloxone

ALBANY – The New York State Department of Corrections and Community Supervision (DOCCS), along with the New York State Department of Health (DOH) and the Harm Reduction Coalition (HRC) announced an Opioid Overdose Prevention training pilot program at the all-male medium-security Queensboro Correctional Facility in Queens. The training will provide inmates preparing for release to the community with education about the dangers of opioid use, as well as training in the use of naloxone, a medication that can be administered to an individual who has overdosed on opioids.

Please click here to read the full press release.

 

^ Return to Top


FDA HIV/AIDS Update: February

Posted February 2015

On February 18, 2015, FDA approved changes to the Isentress (raltegravir) label to include updated information regarding the coadministration of raltegravir and aluminum and/or magnesium containing antacid. Click here for more information.

On February 6, 2015, the FDA approved Dutrebis a fixed dose combination tablet containing 150 mg of lamivudine and 300 mg of raltegravir. Dutrebis tablet is approved for use in combination with other antiretroviral products for the treatment of HIV-1 infection in adults and pediatric patients greater than or equal to 6 years of age weighing at least 30 kg. Click here for more information.

Posted January 2015

On January 29, 2015, FDA approved Prezcobix a fixed dose combination tablet containing 800 mg of darunavir and 150 mg of cobicistat. Click here for more information.

On January 29, 2015, FDA approved Evotaz, a fixed dose combination tablet containing 300 mg of atazanavir and 150 mg of cobicistat. Evotaz is indicated in combination with other antiretroviral agents for the treatment of of human immunodeficiency virus (HIV 1) infection in adults. Click here for more information.

On January 28, 2015 FDA approved changes to the Kaletra (lopinavir/ritonavir) label to include dosing recommendations in pregnant women. Click here for more information.

Merck has decided to voluntarily discontinue the manufacture and distribution of bocepravir (VICTRELIS) in the United States by December 2015. Click here for more information.

For more information, please visit the FDA website at http://www.fda.gov/default.htm

 

^ Return to Top


NQC e-Newsletter | QI Resources for your next QI Event | Feb 15

Posted February 2015

We want to share two interesting profiles in this month’s edition of our e-Newsletter. The work of Family Health Centers and Christa Reece’s work at Harlem Hospital exemplifies the meaning of teamwork to accomplish quality improvement goals to advance HIV care. For more information, check out our “Provider Corner”.

Our quality tip this month also focuses on the importance of working in quality teams to reach your improvement goals. For those of you that have participated in past NQC trainings, you are well aware of the importance of working as teams and what you can accomplish when the team is focused and efficient. Take a look at the resources that we suggest this month.

NQC welcomes input from all of you. Have you found helpful resources for teams? If you have and would like to share them, let us know and we would be happy to pass them along to the Ryan White HIV/AIDS Program community.

Tell us how NQC has helped you | Submit Your Testimony

NQC e-Newsletter

For more information, please visit http://www.nationalqualitycenter.org/

 

^ Return to Top


HIV Training NY: Hetrick-Martin Institute Rolls Out New Training on Trauma among Black and Latino MSM

Posted February 2015

New York State Department of Health AIDS Institute

HIV Training NY

Addressing Trauma among Black and Latino Gay Men and Men Who Have Sex with Men: Do’s and Don’ts for Health and Human Service Providers

Black and Latino gay men and MSM experience disproportionate rates of trauma (including sexual assault), which can impact individual mental health. In this half-day training, participants will learn how to identify trauma in their clients and direct them to appropriate care. The course will review suggestions for creating a safe program environment; how to identify and make referrals; and how to maintain appropriate boundaries with clients.

Dates:

Tuesday, March 3, 2015, 9 am – 12:30 pm (Manhattan)

To register, please go to: http://hivtrainingny.org/Account/LogOn?crs=1316

Thursday, March 12, 2015, 9 am – 12:30 pm (Manhattan)

To register, please go to: http://hivtrainingny.org/Account/LogOn?crs=1317

Thursday, March 19, 2015, 9 am – 12:30 pm (Queens)

To register, please go to: http://hivtrainingny.org/Account/LogOn?crs=1318

To register for any course, click on the appropriate registration link and enter your account log-in information. If you do not have an account with hivtrainingny.org, you will need to sign up for one prior to registering for a course. For registration assistance, please contact the NYSDOH AIDS Institute’s HIV Education and Training Program at (518) 474-3045.

For more information, please visit hivtrainingny.org at http://hivtrainingny.org/

 

^ Return to Top


NYS Clinical Education: New CME Courses and Upcoming Conferences

Posted February 2015

New CME Courses
The Clinical Education Initiative is pleased to announce the availability of three new CME courses. All courses are free and can be taken online at any time.

Please visit http://www.ceitraining.org/sp2/ today to sign-up for these training opportunities.

Upcoming Conferences
Please accept our invitation to participate in these valuable programs. We are at a unique time in the management of HCV and HIV. We hope you will attend.

For more information, please visit http://www.ceitraining.org/

 

^ Return to Top


NYC Health: Health Department Launches New PrEP & PEP Campaign: New Ways to Prevent HIV

Posted January 2015

New PrEP & PEP Detailing Kit to Reach 600 Practices Citywide

Health Department Issues Health Alert to Providers Showing Benefits and Guidelines of PEP

The Health Department today launched a new outreach campaign, PrEP & PEP: New Ways to Prevent HIV, at The Oval Center at Montefiore Medical Center to provide primary care and infectious disease practices with resources to support pre-exposure and post-exposure prophylaxis (PrEP and PEP). Each year, approximately 3,000 New Yorkers are newly diagnosed with HIV. PrEP and PEP are highly effective in preventing HIV when taken as directed. PrEP is a pill taken daily to prevent HIV infection when used in combination with other risk reduction strategies, while PEP is a combination of pills taken daily for 28 days to prevent HIV infection immediately after a high-risk exposure to HIV.

Read the press release

Learn more about PrEP & PEP

 

^ Return to Top


NYC Health Alert Network: Emergency Post-Exposure Prophylaxis Can Prevent HIV Infection

Posted January 2015

Click here to download the NYC Department of Health and Mental Hygiene Health Alert #3 entitled Emergency Post-Exposure Prophylaxis Can Prevent HIV Infection

 

^ Return to Top


Email Announcement Archives

Posted December 2009

The HIV Clinical Guidelines Program provides subscribers with email announcements of when new guidelines are posted and existing guidelines are updated.

hivguidelines email announcement archives

Subscribe to hivguidelines email announcements

 

^ Return to Top


Hot Topics Archive

Please visit the Hot Topics Archive page.

^ Return to Top